Newspaper logo  
 
 
Local News & Opinion

Ref. : Civic Events

Ref. : Arts & Education Events

Ref. : Public Service Notices

Travel
Books, Films, Arts & Education

12.20 How School Segregation Divides Ferguson — and the United States

Letters
Open Letters:

Ref. : Letters to the editor

Health Care & Environment

12.22 ‘I felt like a piece of trash’ – Life inside America’s food processing plants

12.21 GOP Denialism to Sink Capital: 150 Tidal Floods a Year for Washington DC by 2045 [6:32 video, Encroaching Tides' PDF]

12.20 5 Countries where Solar Power is making a Revolution

12.20 British wave power hit by uncertainty over funding, says report

12.20 EPA issues new regulations for handling coal ash

12.20 Green light for world’s largest planned tidal energy project in Scotland

12.19 The World's Biggest Car Company Wants to Get Rid of Gasoline

12.19 Cheaper oil could damage renewable energies, says Richard Branson

News Media

12.19 'Nobody stood up': George Clooney attacks press and Hollywood over Sony hack fallout

12.15 The media treats Dick Cheney like the royals on vacation. He should be in jail

Daily FAIR Blog
The Daily Howler

US Politics, Policy & Culture

12.21 Full Show: The New Robber Barons [25:22 video & transcript]

12.20 A Vermont Senator Asks, Why Not a Socialist President?

12.18 Jeb Bush may be 'the smart brother' – but he's as much of a climate denier as any conservative

12.17 If Elizabeth Warren Says No, What Is Progressives' Backup Plan?

12.16 Michael Brown, Eric Garner, and the 'Other America'

12.16 Something snapped for defeated Democrats in bruising budget battle

Justice Matters

12.18 S.C. boy executed for 1944 murder is exonerated

12.17 Los Angeles lawyers stage die-in protest against police – video

High Crimes?

12.22 The *Other* Torture Report: What the USA looks like to the World

12.19 The lack of any official condemnation for CIA torture ensures it will happen again

12.18 The Depravity Of Dick Cheney

Economics, Crony Capitalism

12.22 Water privatization bill removing public vote requirement moves to Christie's desk

12.22 This Is the Stupidest Anti-Science Bullshit of 2014

12.20 Russian Roulette: Taxpayers Could Be on the Hook for Trillions in Oil Derivatives

12.19 Bleeding the IRS Will Make the Tax System Worse

12.18 Joseph Stiglitz: Economics Must Address Wealth and Income Inequality

12.18 Wealth Gap between America’s Rich and Middle-Class Families Widest on Record [charts]

12.18 Coal, an Outlaw Enterprise

International

12.22 India's bride trafficking fuelled by skewed sex ratios

12.22 The best city blogs around the world – an interactive guide [interactive graphic]

12.22 The smartest cities rely on citizen cunning and unglamorous technology

12.22 South Korea launches nuclear power cyber-attack drills after hack

12.20 Turkey’s Descent Into Paranoia

12.20 Sean Penn on Sony Pulling "The Interview": This Sends ISIS an "Invitation"

12.20 North Korea proposes joint inquiry with US into Sony Pictures hack

12.20 The Pope Francis stardust worked over Cuba. Could it work with Isis and the Taliban?

12.20 Sony pulling The Interview was 'a mistake' says Obama

12.19 MATERIAL QUESTION

12.19 2014 science breakthroughs: no more ageing, cave art and landing on a comet

12.19 Hyperloop Reality Check: Elon Musk's High-Speed Scheme Is Alive And Kicking

We are a non-profit Internet-only newspaper publication founded in 1973. Your donation is essential to our survival.

You can also mail a check to:
Baltimore News Network, Inc.
P.O. Box 42581
Baltimore, MD 21284-2581
Google
This site Web
  Big Pharma Wins Big in Health Care Reform

COMMENTARY:

Big Pharma Wins Big in Health Care Reform

by James Ridgeway
First published in his blog Unsilent Generation yesterday, 22 March 2010
To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

The Republicans look a sour lot this morning, but the pharmaceutical industry, which helps foot the campaign bills of a sizeable chunk of members of both parties, is delighted with the legislation, and with its Democratic friends in the White House and on the Hill.

Members of Congress in both parties generally have lined up behind the insurance and pharmaceutical industries from the get go. So it should come as no surprise that the Democrats, who long ago gave up any pretence of opposing corporate power, found a way to accomodate the pharmaceutical companies on the way to its tepid reform. To a large extent, the “debate” over health care was a show debate, an extended round of Washington smoke and mirrors. The administration early on cut its deal with Big Pharma, and pretty much stuck to it throughout the process.

In fact, the Dems actually made the drugsters look good, celebrating the industry’s generous “concessions” and “discounts” while ensuring that no real threat to Big Pharma’s profits would make their way into the final bill.

The industry’s main goal from the very beginning has been to fend off any government power to negotiate or seriously regulate drug prices–and this they did.

Big Pharma’s second big win was to prevent any measure that would have opened the way for American consumers to buy less expensive drugs abroad, especially from Canada.

At the same time, the supposed give-backs by the drug industry are projected to more than pay for themselves. The much-lauded discounts on brand name drugs for seniors in the Medicare prescription drug program, for example, are good for Big Pharma because they discourage oldsters from switching to generics.

And more insured people simply mean more money coming into the coffers, for Big Pharma as well as for the insurance industry.

Confirmation of the industry analysis came early in the day from the stock market, where drug stocks initially remained level; there certainly was no rush to dump shares, which is what would be expected if the bill actually represented any threat to profits. And by 1 p, EST, CNN Money was reporting a rally in health care stocks.

“I was unable to find anything in there that would cause me to have anxiety if I were a shareholder in a pharmaceutical company,” Ira Loss, a senior health-care analyst at the research firm Washington Analysis, told Dow Jones. According to the ticker story:

Billy Tauzin, who led the industry’s negotiations on health care with lawmakers, said overall drug makers fare well. “While we’re not totally happy,” Tauzin began, “we generally feel like it tracks with our principles.”

Sanofi-Aventis SA (SNY) Chief Executive Christopher Viehbacher said in an interview that the impact of the legislation will be neutral to slightly negative “but better for the industry than if healthcare reform didn’t pass.”

Tauzin, head of the Pharmaceutical Research and Manufacturers of America or PhRMA, and Viehbacher said getting protection for brand-name biologics is among the important provisions for the industry. Drug makers pushed hard to get 12 years of exclusive market protection while the White House and some lawmakers wanted to lower the protection to seven years.

Despite fees and rebates imposed by the legislation, “analysts say drug makers will end up recouping those costs through new customers: The bill would provide insurance coverage to an additional 32 million Americans.” The Dow Jones story continues:

Chalk up another good round for Pharma and Biotech in health care reform,” began a note to clients Friday from Concept Capital, a research firm.Ken Tsuboi, co-manager of the Allianz RCM Wellness Fund, sees the impact of bill, and its $90 billion in concessions over 10 years, as relatively minor in an industry that has annual global sales of about $750 billion, with about $300 billion in the U.S., and margins close to 30%.”I think that it is actually a pretty good deal for Pharma,” Tsuboi said.

The GOP, which purports to be the party of big business, ought to be applauding at least these portions of the health care reform—and perhaps when the cameras go away, some of them will quit bitching and count their blessings. As for the obnoxious Tea Party gang, if they start threatening the real power in this country, which is vested in corporations, they may well find themselves whipped and isolated.


Born in 1936, James Ridgeway has been reporting on politics for more than 45 years. He is currently Senior Washington Correspondent for Mother Jones, and recently wrote a blog on the 2008 presidential election for the Guardian online. He previously served as Washington Correspondent for the Village Voice; wrote for Ramparts and The New Republic; and founded and edited two independent newsletters, Hard Times and The Elements.

Ridgeway is the author of 16 books, including The Five Unanswered Questions About 9/11, It’s All for Sale: The Control of Global Resources, and Blood in the Face: The Ku Klux Klan, Aryan Nations, Nazi Skinheads, and the Rise of a New White Culture. He co-directed a companion film to Blood in the Face and a second documentary film, Feed, and has co-produced web videos for GuardianFilms.

Additional information and samples of James Ridgeway’s work can be found at JamesRidgeway.net and at his newest web site, Solitary Watch.

This article is republished in the Baltimore Chronicle with permission of the author.



Copyright © 2010 The Baltimore News Network. All rights reserved.

Republication or redistribution of Baltimore Chronicle content is expressly prohibited without their prior written consent.

Baltimore News Network, Inc., sponsor of this web site, is a nonprofit organization and does not make political endorsements. The opinions expressed in stories posted on this web site are the authors' own.

This story was published on March 23, 2010.
 



Public Service Ads:
Verifiable Voting in Maryland